Effect of co‐dergocrine in the autoperfused superior mesenteric vascular bed of the rat
- 1 June 1991
- journal article
- Published by Wiley in Journal of Autonomic Pharmacology
- Vol. 11 (3) , 155-165
- https://doi.org/10.1111/j.1474-8673.1991.tb00315.x
Abstract
1 The influence of local administration of co-dergocrine in the in situ, constant flow autoperfused, superior mesenteric vascular bed of the rat was investigated. 2 Local infusion of co-dergocrine (0.1-mu-g kg-1 min-1) reduced the pressor response to electrical stimulation of the periarterial sympathetic nerves for the whole frequency range studied during cumulative frequency-response curves (1-8 Hz). 3 Co-dergocrine (0.01, 0.03, 0.1-mu-g kg-1 min-1) dose-dependently inhibited the pressor response to electrical stimulation at 4 Hz; increases in perfusion pressure produced by locally administered noradrenaline were inhibited to the same degree. 4 Pressor responses induced by locally administered phenylephrine were also inhibited by co-dergocrine (0.1-mu-g kg-1 min-1) while those produced by local injection of angiotensin II were not. 5 Local administration of the DA1-/DA2-receptor antagonist haloperidol (1-mu-g kg-1), the DA2-receptor antagonist domperidone (10-mu-g kg-1) and the alpha-2-adrenoceptor antagonist rauwolscine (100-mu-g kg-1) partially prevented the influence of co-dergocrine on the electrically induced response. 6 The results show that the effect of co-dergocrine in the rat superior mesenteric vascular bed cannot simply be ascribed to interaction with the presynaptic inhibitory DA2-receptors on the noradrenergic nerve endings; it also has an antagonistic action at the postsynaptic alpha-1-adrenoceptors and an agonist action at the presynaptic alpha-2-adrenoceptorsKeywords
This publication has 25 references indexed in Scilit:
- Dihydroergotoxine-induced Bradycardia in RatsJournal of Pharmacy and Pharmacology, 1988
- Is Stimulation of Prejunctional Dopamine Receptors an Antihypertensive Principle?Clinical and Experimental Hypertension. Part A: Theory and Practice, 1987
- Subclassification of Peripheral Dopamine ReceptorsClinical and Experimental Hypertension. Part A: Theory and Practice, 1987
- Peripheral dopamine receptors in the antihypertensive action of dihydroergotoxine in humans.Hypertension, 1987
- PHARMACOLOGICAL CHARACTERIZATION OF NEURONAL DOPAMINE RECEPTORS IN THE RAT HINDQUARTERS, RENAL AND SUPERIOR MESENTERIC VASCULAR BEDSJournal of Autonomic Pharmacology, 1986
- Dihydroergotoxine decreases blood pressure in spontaneously hypertensive rats by interacting with peripheral dopamine receptorsLife Sciences, 1985
- Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents: Part II: Sites and mechanisms of action of dopamine receptor agonistsLife Sciences, 1982
- CARDIOVASCULAR DOPAMINE RECEPTORS: PHYSIOLOGICAL, PHARMACOLOGICAL AND THERAPEUTIC IMPLICATIONSJournal of Autonomic Pharmacology, 1982
- Actions of Co-Dergocrine mesylate and its components at vascular smooth muscleNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1982